BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 38727302)

  • 1. The Invasion Factor ODZ1 Is Upregulated through an Epidermal Growth Factor Receptor-Induced Pathway in Primary Glioblastoma Cells.
    Velasquez C; Gutierrez O; Carcelen M; Fernandez-Luna JL
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma.
    Choi BD; Gerstner ER; Frigault MJ; Leick MB; Mount CW; Balaj L; Nikiforow S; Carter BS; Curry WT; Gallagher K; Maus MV
    N Engl J Med; 2024 Apr; 390(14):1290-1298. PubMed ID: 38477966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities.
    Ezzati S; Salib S; Balasubramaniam M; Aboud O
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional role of p38 MAPK pathway in malignant brain tumors.
    Grave N; Scheffel TB; Cruz FF; Rockenbach L; Goettert MI; Laufer S; Morrone FB
    Front Pharmacol; 2022; 13():975197. PubMed ID: 36299892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p38 MAP kinase in cancer stem cells and metastasis.
    Kudaravalli S; den Hollander P; Mani SA
    Oncogene; 2022 Jun; 41(23):3177-3185. PubMed ID: 35501462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF2α Upregulates the Migration Factor ODZ1 under Hypoxia in Glioblastoma Stem Cells.
    Carcelén M; Velásquez C; Vidal V; Gutierrez O; Fernandez-Luna JL
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054927
    [No Abstract]   [Full Text] [Related]  

  • 7. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
    Ostrom QT; Cioffi G; Waite K; Kruchko C; Barnholtz-Sloan JS
    Neuro Oncol; 2021 Oct; 23(12 Suppl 2):iii1-iii105. PubMed ID: 34608945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma invasion factor ODZ1 is induced by microenvironmental signals through activation of a Stat3-dependent transcriptional pathway.
    Vidal V; Gutierrez O; Talamillo A; Velasquez C; Fernandez-Luna JL
    Sci Rep; 2021 Aug; 11(1):16196. PubMed ID: 34376733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of EGFR Resistance in Glioblastoma.
    Pan PC; Magge RS
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38β and Cancer: The Beginning of the Road.
    Roche O; Fernández-Aroca DM; Arconada-Luque E; García-Flores N; Mellor LF; Ruiz-Hidalgo MJ; Sánchez-Prieto R
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.
    Sundqvist A; Vasilaki E; Voytyuk O; Bai Y; Morikawa M; Moustakas A; Miyazono K; Heldin CH; Ten Dijke P; van Dam H
    Oncogene; 2020 May; 39(22):4436-4449. PubMed ID: 32350443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma.
    Muñoz-Hidalgo L; San-Miguel T; Megías J; Monleón D; Navarro L; Roldán P; Cerdá-Nicolás M; López-Ginés C
    Neoplasia; 2020 Jan; 22(1):10-21. PubMed ID: 31751860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia Can Induce Migration of Glioblastoma Cells Through a Methylation-Dependent Control of
    Velásquez C; Mansouri S; Gutiérrez O; Mamatjan Y; Mollinedo P; Karimi S; Singh O; Terán N; Martino J; Zadeh G; Fernández-Luna JL
    Front Oncol; 2019; 9():1036. PubMed ID: 31649891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11.
    Li Y; Kong C; Wu C; Wang Y; Xu B; Liang S; Ying X
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31123170
    [No Abstract]   [Full Text] [Related]  

  • 15. Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?
    Lefranc F; Le Rhun E; Kiss R; Weller M
    Cancer Treat Rev; 2018 Jul; 68():145-154. PubMed ID: 30032756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Signatures for Tumor Classification: An Analysis of The Cancer Genome Atlas Data.
    Mamatjan Y; Agnihotri S; Goldenberg A; Tonge P; Mansouri S; Zadeh G; Aldape K
    J Mol Diagn; 2017 Nov; 19(6):881-891. PubMed ID: 28867603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.
    Talamillo A; Grande L; Ruiz-Ontañon P; Velasquez C; Mollinedo P; Torices S; Sanchez-Gomez P; Aznar A; Esparis-Ogando A; Lopez-Lopez C; Lafita C; Berciano MT; Montero JA; Vazquez-Barquero A; Segura V; Villagra NT; Pandiella A; Lafarga M; Leon J; Martinez-Climent JA; Sanz-Moreno V; Fernandez-Luna JL
    Oncogene; 2017 Mar; 36(12):1733-1744. PubMed ID: 27641332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 Mitogen-Activated Protein Kinase Pathway Regulates Genes during Proliferation and Differentiation in Oligodendrocytes.
    Haines JD; Fulton DL; Richard S; Almazan G
    PLoS One; 2015; 10(12):e0145843. PubMed ID: 26714323
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.